Incannex Healthcare Limited
IXHL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $19 | $109 |
| % Growth | – | -100% | -82.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $67 | $0 | $19 | $109 |
| % Margin | – | – | 100% | 100% |
| R&D Expenses | $9,333 | $4,568 | $2,284 | $4,265 |
| G&A Expenses | $9,526 | $3,788 | $5,819 | $5,055 |
| SG&A Expenses | $9,526 | $3,788 | $5,819 | $5,055 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$3,087 | $0 | $0 | $0 |
| Operating Expenses | $15,772 | $8,355 | $8,103 | $9,320 |
| Operating Income | -$12,531 | -$8,355 | -$8,083 | -$9,211 |
| % Margin | – | – | -41,701.5% | -8,451.4% |
| Other Income/Exp. Net | -$23,041 | $1,729 | -$1,438 | $1,228 |
| Pre-Tax Income | -$35,572 | -$6,627 | -$9,521 | -$7,983 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$35,572 | -$6,627 | -$9,521 | -$7,983 |
| % Margin | – | – | -49,118.4% | -7,324.3% |
| EPS | -1.03 | -0.2 | -0.33 | -0.29 |
| % Growth | -415% | 39.4% | -13.8% | – |
| EPS Diluted | -1.03 | -0.2 | -0.33 | -0.29 |
| Weighted Avg Shares Out | 34,454 | 19,633 | 17,624 | 17,643 |
| Weighted Avg Shares Out Dil | 34,454 | 19,633 | 17,624 | 17,643 |
| Supplemental Information | – | – | – | – |
| Interest Income | $34 | $7 | $45 | $41 |
| Interest Expense | $132 | $220 | $276 | $0 |
| Depreciation & Amortization | $42 | -$8 | $204 | $94 |
| EBITDA | -$39,051 | -$6,406 | -$9,041 | -$7,922 |
| % Margin | – | – | -46,643.3% | -7,268.9% |